Biodesix Price to Free Cash Flow Ratio 2020-2024 | BDSX
Historical price to free cash flow ratio values for Biodesix (BDSX) since 2020.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Biodesix Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-05-02 | 0.52 | 0.00 | |
| 2024-12-31 | 1.53 | $-0.40 | 0.00 |
| 2024-09-30 | 1.78 | $-0.50 | 0.00 |
| 2024-06-30 | 1.53 | $-0.58 | 0.00 |
| 2024-03-31 | 1.43 | $-0.52 | 0.00 |
| 2023-12-31 | 1.84 | $-0.56 | 0.00 |
| 2023-09-30 | 1.65 | $-0.68 | 0.00 |
| 2023-06-30 | 1.23 | $-0.82 | 0.00 |
| 2023-03-31 | 1.86 | $-0.91 | 0.00 |
| 2022-12-31 | 2.30 | $-1.15 | 0.00 |
| 2022-09-30 | 1.27 | $-1.26 | 0.00 |
| 2022-06-30 | 1.64 | $-1.31 | 0.00 |
| 2022-03-31 | 1.69 | $-1.10 | 0.00 |
| 2021-12-31 | 5.29 | $-1.11 | 0.00 |
| 2021-09-30 | 8.22 | $-5.52 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.076B | $0.071B |
| Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado. | |||